SWOG clinical trial number
S0423

Phase II Trial of Pemetrexed for Advanced Chondrosarcomas

19% Accrual
Accrual
19%
Closed
Phase
19% Accrual
Accrual
19%
Abbreviated Title
Chondrosarcoma
Activated
09/01/2005
Closed
01/15/2007
Participants
NCORP, Members, Surgeons, Pathologists, CTSU Institutions in the United States, Intergroup Coalition Against Sarcomas Members in the United States

Research committees

Sarcoma

Treatment

Pemetrexed